Promising immunotherapy drug to treat peanut allergies may be approved although 10% of study subjects had serious side effects

x

On [September 13], a panel of experts assembled by the Food and Drug Administration voted that the agency should approve a drug called Palforzia designed to help people manage their peanut allergy. But the non-unanimous verdict rendered by the panel highlights the ongoing debate over whether this therapy, a pill containing peanut protein, is actually worthwhile for patients to take.

The treatment is known as oral immunotherapy, and it works by purposefully exposing someone to a tiny amount of the allergen, with the hope that small doses given over a long enough time can desensitize the person’s hyperactive immune system.

Over 10 percent of people taking Palforzia discontinued the treatment, often because they couldn’t stand the side-effects they experienced. These side-effects included anaphylaxis.

Related article:  Expensive CAR-T therapy raises difficult question: 'What is the price of a human life?'

Outside researchers have documented these risks, seen across many clinical trials of peanut oral immunotherapy. And given that people are taking the treatment to avoid severe allergic reactions, some have argued that the risks might outweigh the benefits. It was that same rationale that led two of the nine voting experts to recommend against approving the drug.

Read full, original post: The First Peanut Allergy Drug Might Be Approved Soon—but Not Without Controversy

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
can you boost your immune system to prevent coronavirus spread x

Video: How to boost your immune system to guard against COVID and other illnesses

Scientists have recently developed ways to measure your immune age. Fortunately, it turns out your immune age can go down ...
mag insects image superjumbo v

Disaster interrupted: Which farming system better preserves insect populations: Organic or conventional?

A three-year run of fragmentary Armageddon-like studies had primed the journalism pumps and settled the media framing about the future ...
dead bee desolate city

Are we facing an ‘Insect Apocalypse’ caused by ‘intensive, industrial’ farming and agricultural chemicals? The media say yes; Science says ‘no’

The media call it the “Insect Apocalypse”. In the past three years, the phrase has become an accepted truth of ...
globalmethanebudget globalcarbonproject cropped x

Infographic: Cows cause climate change? Agriculture scientist says ‘belching bovines’ get too much blame

A recent interview by Caroline Stocks, a UK journalist who writes about food, agriculture and the environment, of air quality ...
organic hillside sweet corn x

Organic v conventional using GMOs: Which is the more sustainable farming?

Many consumers spend more for organic food to avoid genetically modified products in part because they believe that “industrial agriculture” ...
benjamin franklin x

Are most GMO safety studies funded by industry?

The assertion that biotech companies do the research and the government just signs off on it is false ...
gmo corn field x

Do GMO Bt (insect-resistant) crops pose a threat to human health or the environment?

Bt is a bacterium found organically in the soil. It is extremely effective in repelling or killing target insects but ...
favicon

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies for tighter GMO legislation and famously puts out annual "dirty dozen" list of fruits and ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be the prime mover behind the ongoing campaign against agricultural biotechnology at Consumer Reports. He is an ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend